Bright Eye Hospital Group301239.SZValuation Analysis

As of Oct 19, 2026, Bright Eye Hospital Group (301239.SZ) trades at a P/E of 394.00x, P/B of 2.32x, P/S of 1.54x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 88th percentile over the trailing 10Y window (vs. 94th percentile over 3Y); P/B sits at the 12th percentile over the trailing 10Y window (vs. 16th percentile over 3Y); P/S sits at the 11th percentile over the trailing 10Y window (vs. 15th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 96th percentile within its industry and the 96th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
Notably, P/E and P/B aren't telling quite the same story, 76.5 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Bright Eye Hospital Group operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.